Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates May 15, 2025 07:30AM
Elevation Oncology (ELEV) to Discontinue Development of EO-3021 Mar 20, 2025 08:01AM
Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options Mar 20, 2025 08:00AM
Elevation Oncology (ELEV) Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition Jan 6, 2023 08:15AM
Elevation Oncology Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition Jan 6, 2023 08:15AM